Skip to main content

Table 3 Effect of Zingiber officinal e extracts on hepatic marker enzymes in CCl4 treated rats

From: Zingiber officinale acts as a nutraceutical agent against liver fibrosis

Parameters Control CCl4 group CCl4 treated with ethanol extract
ethanol extract
CCl4 treated with chloroform extract
chloroform extract
CCl4 treated with
petroleum ether extract
CCl4 treated with silymarin
SDH 108.86 ± 24.2
(a)
84.2 ± 24.2
(b)
99.28 ± 10.05
(ab)
93.79 ± 6.79
(ab)
96.16 ± 23.51
(ab)
91.16 ± 8.29
(ab)
LDH 143.86 ± 18.12
(a)
97.01 ± 41.09
(c)
124.04 ± 27.63
(abc)
100.83 ± 12.93
(bc)
140.06 ± 2.44
(a)
131.2 ± 35.16
(ab)
G-6-Pase 43.48 ± 4.83
(a)
32.87 ± 2.24
(b)
36.97 ± 10.31
(ab)
34.07 ± 7.9
(b)
36.55 ± 2.39
(ab)
36.65 ± 6.33
(ab)
AP 63.53 ± 6.73
(a)
41.21 ± 2.55
(d)
54.3 ± 3.01
(b)
48.25 ± 3.14
(c)
48.35 ± 4.79
(c)
46.41 ± 3.19
(c)
5'NT 304.25 ± 58.81
(a)
160.83 ± 29.38
(d)
238.17 ± 5.79
(b)
215.63 ± 21.42
(bc)
192.18 ± 14.9
(cd)
214.9 ± 47.4
(bc)
  1. Data are means ± SD of eight rats in each group.
  2. Data are expressed as μmole/min/mg protein.
  3. Unshared letters between groups are the significance values at p < 0.0001.
  4. Statistical analysis is carried out using one way analysis of variance (ANOVA), CoStat Computer Program.